Interleukin-1B polymorphism is associated with age at onset of Alzheimer's disease

Neurobiol Aging. 2003 Nov;24(7):927-31. doi: 10.1016/s0197-4580(03)00011-3.

Abstract

Interleukin-1alpha (IL-1alpha) and IL-1beta are two pro-inflammatory cytokines involved in the pathogenesis of Alzheimer's disease (AD). The genes coding for IL-1alpha (IL-1A) and for IL-1beta (IL-1B) are clustered in chromosome 2q14-2q14.2. In a previous work, we investigated the role of IL-1A promoter polymorphism (-889 position) in AD pathogenesis: IL-1A -889 TT genotype was associated with sporadic early onset AD. We now report the study on polymorphism of exon 5 IL-1B in position +3953, the nearest polymorphism to -889 IL-1A. We found that the genotype distribution of IL-1B +3953 varied significantly between patients with early and late onset of AD (P<0.0001). Patients carrying IL-1B +3953 CT or TT genotypes had 4 or 5 years anticipation of AD onset (P=0.0034; odds ratio for early onset, 3.01) and 7 years anticipation if they also carried the IL-1A -889 TT genotype (P<0.0001; odds ratio for early onset, 7.4). These data further support a role for inflammation-related genes in AD or indicate linkage disequilibrium with an unknown chromosome 2 locus.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Alzheimer Disease / genetics*
  • Apolipoproteins E / genetics
  • Chromosomes, Human, Pair 2 / genetics*
  • Female
  • Genetic Predisposition to Disease
  • Humans
  • Interleukin-1 / genetics*
  • Italy
  • Linkage Disequilibrium
  • Male
  • Matched-Pair Analysis
  • Middle Aged
  • Polymorphism, Genetic*
  • Reference Values

Substances

  • Apolipoproteins E
  • Interleukin-1